Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial.
Lancet Respir Med
; 7(7): 594-604, 2019 07.
Article
in En
| MEDLINE
| ID: mdl-31178422
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Sulfonamides
/
Endothelin Receptor Antagonists
/
Pulmonary Arterial Hypertension
/
Hypertension, Portal
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet Respir Med
Year:
2019
Document type:
Article
Country of publication:
United kingdom